cdk4 glutathione Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix: Molecular Cell Targeting CDK4/6 for Anticancer Therapy
Targeting CDK4 6 for Anticancer Therapy MYC induces CDK4 6 inhibitors resistance by promoting pRB1 degradation Nature Communications Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv The application and prospect of CDK4 6 inhibitors in malignant solid tumors Journal of Hematology & Oncology Springer Nature Link Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4 6 Inhibition Elicits Unique Vulnerabilities ScienceDirect
Pay in 4 interest-free payments of $5.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




